PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Spaulding Clinical Research, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Spaulding Clinical Research, LLC Wins CRO Leadership Award - Spaulding Clinical receives top CRO award for two years straight - SpauldingClinical.com
Spaulding Clinical Research, LLC Wins CRO Leadership Award

 

NewswireToday - /newswire/ - West Bend, WI, United States, 2015/06/15 - Spaulding Clinical receives top CRO award for two years straight - SpauldingClinical.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Spaulding Clinical Research, LLC (SCR) announced it has been recognized for excellence in clinical research by biopharmaceutical executives surveyed for the Life Science Leader magazine’s 2015 CRO Leadership Awards.

SCR was named a two-category winner for quality and innovation for the second year in a row, based on survey responses from more than 2,300 industry executives responsible for making or influencing decisions to outsource clinical development programs to contract research organizations (CROs).

“Spaulding Clinical is honored to receive recognition from the biopharmaceutical industry for quality and innovation for the second year in a row,” said Randol Spaulding, Founder and CEO of SCR. “Innovation and quality run deep at Spaulding Clinical and these awards are a testament to our dedicated professionals and the ingenious solutions they strive for every day.”

Life Science Leader developed the annual CRO Leadership Awards in 2012 to honor top performers based on leading industry research conducted by professional market research agency Nice Insight. For this year's program, Life Science Leader narrowed the field of award winners by selecting only those companies that placed in the top 10% of each category.

About Spaulding Clinical Research, LLC

SCR (spauldingclinical.com) is a global CRO providing Phase I - IV drug development services to the biopharmaceutical industry. Spaulding Clinical Research operates a 165 bed Clinical Pharmacology Unit, a Core ECG Laboratory and provides full Biometrics/Scientific Affairs services.

About the Awards

Life Science Leader’s readership of pharmaceutical and biopharmaceutical executives have told us about their struggles in vetting CRO partners. In response, Life Science Leader developed the CRO Leadership Awards based on industry research conducted by Nice Insight. The awards incorporate common filters used by pharma companies to vet CROs with the added filter of peer feedback. Unlike other industry awards which are given based on a voting or nomination process, the only votes that count towards the CRO Leadership Awards are those of the pharmaceutical and biopharmaceutical companies using CRO services. This helps pharma and biopharma companies focus on potential CRO partners who can handle their projects and are considered reputable in the industry.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Spaulding Clinical Research, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Spaulding Clinical Research, LLC Wins CRO Leadership Award

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Tyler Borst - SpauldingClinical.com 
262-334-6020 tyler.borst[.]spauldingclinical.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Spaulding Clinical Research, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Spaulding Clinical Research, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)